Arcus Biosciences (RCUS) EBITDA Margin Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - | -44,424.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,424.00 |
| Dec 31, 2025 | -12,781.00 |
| Sep 30, 2025 | -34,168.00 |
| Jun 30, 2025 | 25,136.00 |
| Mar 31, 2025 | -3,909.00 |
| Dec 31, 2024 | -47,460.00 |
| Sep 30, 2024 | 60,591.00 |
| Jun 30, 2024 | 53,165.00 |
| Mar 31, 2024 | 75,674.00 |
| Dec 31, 2023 | -10,304.00 |
| Sep 30, 2023 | -25,273.00 |
| Jun 30, 2023 | 229,768.00 |
| Mar 31, 2023 | 122,909.00 |
| Dec 31, 2022 | -4,752.00 |
| Sep 30, 2022 | 107,616.00 |
| Jun 30, 2022 | 134,399.00 |
| Mar 31, 2022 | 60,532.00 |
| Dec 31, 2021 | 86,552.00 |
| Sep 30, 2021 | -57,211.00 |
| Jun 30, 2021 | 27,807.00 |
| Mar 31, 2021 | 27,295.00 |
| Dec 31, 2020 | 51,248.00 |
| Sep 30, 2020 | 1.42 Mn |